These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12635454)

  • 1. Effect of pharmacist counseling in patients hospitalized with acute exacerbation of asthma.
    Stiegler KA; Yunker NS; Crouch MA
    Am J Health Syst Pharm; 2003 Mar; 60(5):473-6. PubMed ID: 12635454
    [No Abstract]   [Full Text] [Related]  

  • 2. What is "more effective asthma control"?
    O'Brien K; Bukstein D
    J Allergy Clin Immunol; 2001 Jun; 107(6):1107-9. PubMed ID: 11398094
    [No Abstract]   [Full Text] [Related]  

  • 3. In patients with asthma that is not well controlled with inhaled steroids, does salmeterol (Serevent) or montelukast (Singulair) offer better symptom relief?
    Cash R; Blonski J
    J Fam Pract; 2001 Sep; 50(9):802. PubMed ID: 11674917
    [No Abstract]   [Full Text] [Related]  

  • 4. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
    Virchow JC
    Chest; 2002 Jun; 121(6):2083-4. PubMed ID: 12065391
    [No Abstract]   [Full Text] [Related]  

  • 5. Increasing compliance with inhaled corticosteroids through the use of combination therapy.
    Holt S; Masoli M; Beasley R
    J Allergy Clin Immunol; 2004 Feb; 113(2):219-20. PubMed ID: 14767433
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral montelukast versus inhaled salmeterol to prevent exercise-induced bonchonconstriction.
    Brestel EP
    Ann Intern Med; 2000 Sep; 133(5):392; author reply 392-3. PubMed ID: 10979887
    [No Abstract]   [Full Text] [Related]  

  • 7. Health care utilization determined from administrative claims analysis for patients who received inhaled corticosteroids with either montelukast or salmeterol.
    Markson LE; Bukstein DA; Luskin AT
    J Manag Care Pharm; 2006; 12(6):486-7; author reply 487-9. PubMed ID: 16925457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral montelukast versus inhaled salmeterol to prevent exercise-induced bronchoconstriction.
    Grieco AJ; Burstein-Stein J
    Ann Intern Med; 2000 Sep; 133(5):392; author reply 392-3. PubMed ID: 10979888
    [No Abstract]   [Full Text] [Related]  

  • 9. Salmeterol xinafoate in children.
    Robertson CF; Mellis C; Staugas R; Isles AF; Landau LI
    Med J Aust; 1995 Apr; 162(8):443. PubMed ID: 7746185
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of rhinitis medications in children receiving initial controller therapy for asthma.
    Stempel DA; Stanford RH; Carranza Rosenzweig JR; McLaughlin TP
    Curr Med Res Opin; 2006 Nov; 22(11):2279-85. PubMed ID: 17076988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting beta-agonists, tachyphylaxis, and corticosteroids.
    Sears MR
    Chest; 1996 Apr; 109(4):862-4. PubMed ID: 8635359
    [No Abstract]   [Full Text] [Related]  

  • 12. [What helps for persistent symptoms of asthma during inhalative steroid therapy?].
    Kroegel C
    Dtsch Med Wochenschr; 2011 Oct; 136(42):2130. PubMed ID: 21990055
    [No Abstract]   [Full Text] [Related]  

  • 13. PP-ICONS--another tool to help interpret asthma utilization studies.
    Crownover BK
    J Manag Care Pharm; 2006 May; 12(4):341-2. PubMed ID: 16792440
    [No Abstract]   [Full Text] [Related]  

  • 14. Adherence to asthma controller medication regimens.
    Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI).
    Ann Allergy Asthma Immunol; 2000 May; 84(5):475-80. PubMed ID: 10830999
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW; Stempel DA; Meyer J; Stanford RH; Carranza Rosenzweig JR
    J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast and airway remodeling in children with chronic persistent asthma: an open study.
    Pifferi M; Caramella D; Ragazzo V; De Marco E; Pietrobelli A; Boner AL
    Pediatr Allergy Immunol; 2004 Oct; 15(5):472-3. PubMed ID: 15482525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of add-on therapy to inhaled fluticasone propionate in children with asthma: residual volume and exhaled nitric oxide as outcome measures.
    Verini M; Peroni DG; Piacentini GL; Nicodemo A; Rossi N; Bodini A; Chiarelli F; Boner AL
    Allergy Asthma Proc; 2007; 28(6):691-4. PubMed ID: 18201433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SIMPLE trial.
    D'Urzo AD
    Can Respir J; 2010; 17(2):56. PubMed ID: 20422059
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugs for asthma.
    Med Lett Drugs Ther; 2000 Mar; 42(1073):19-24. PubMed ID: 10755001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.